Search results
Showing 226 to 240 of 1002 results for public health medicine & health
Maralixibat for treating cholestatic pruritus in Alagille syndrome [ID3941]
In development Reference number: GID-TA10832 Expected publication date: TBC
We are listening to your views on this Technology appraisal guidance. Comments close 29 June 2026.
We are listening to your views on this Technology appraisal guidance. Comments close 22 July 2026.
Secukinumab for treating relapsed polymyalgia rheumatica ID6599
In development Reference number: GID-TA11806 Expected publication date: TBC
Teclistamab for treating relapsed or refractory multiple myeloma after 1 or more treatments ID6628
In development Reference number: GID-TA11826 Expected publication date: TBC
Awaiting development Reference number: GID-TA11813 Expected publication date: TBC
We are listening to your views on this Technology appraisal guidance. Comments close 13 August 2026.
In development Reference number: GID-TA11815 Expected publication date: TBC
Sole supplied titles are distinct journal and book collections that can be purchased from Lot 1 of our purchasing framework.
Tell us what matters to you, your organisation or your community.
Tell us what matters to you, your organisation or your community.
Percutaneous thrombectomy for intermediate-risk and high-risk acute pulmonary embolism
In development Reference number: GID-HTG10169 Expected publication date: 07 April 2027
This manual sets out the process for how new guidance topics and updates to existing NICE guidance are identified, prioritised and routed at NICE, and the decision-making framework used by the NICE prioritisation board
In development Reference number: GID-TA11812 Expected publication date: 13 January 2027
Doxecitine–doxribtimine for treating thymidine kinase 2 deficiency in people of any age [ID6484]
In development Reference number: GID-HST10063 Expected publication date: TBC